Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion.

Saleh MC, Connell BJ, Rajagopal D, Khan BV, Abd-El-Aziz AS, Kucukkaya I, Saleh TM.

PLoS One. 2014 Jan 31;9(1):e87865. doi: 10.1371/journal.pone.0087865. eCollection 2014.

2.

Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan.

Khan BV, Merchant N, Rahman ST, Ahmad M, Parrott JM, Umar K, Johnson J, Ferdinand KC.

Cardiorenal Med. 2013 Dec;3(4):221-31. doi: 10.1159/000355136. Epub 2013 Oct 2.

3.

UPEI-300, a conjugate of lipoic acid and edaravone, mediates neuroprotection in ischemia/reperfusion.

Connell BJ, Saleh MC, Kucukkaya I, Abd-El-Aziz AS, Khan BV, Saleh TM.

Neurosci Lett. 2014 Feb 21;561:151-5. doi: 10.1016/j.neulet.2013.12.060. Epub 2014 Jan 3.

PMID:
24394910
4.

Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial.

Giles TD, Khan BV, Lato J, Brener L, Ma Y, Lukic T.

J Clin Hypertens (Greenwich). 2013 Sep;15(9):687-93. doi: 10.1111/jch.12169. Epub 2013 Jul 16.

5.

Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartan.

Merchant N, Rahman ST, Ahmad M, Parrott JM, Johnson J, Ferdinand KC, Khan BV.

J Am Soc Hypertens. 2013 Sep-Oct;7(5):386-94. doi: 10.1016/j.jash.2013.05.001. Epub 2013 Jul 5.

PMID:
23835112
6.

Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA study.

Khan BV, Rahman ST, Haque T, Merchant N, Bhaheetharan S, Harris J 3rd, Umar K, Wahi J, Ferdinand KC.

J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):291-7. doi: 10.1177/1074248412436607. Epub 2012 Mar 2.

PMID:
22388001
7.

UPEI-100, a conjugate of lipoic acid and apocynin, mediates neuroprotection in a rat model of ischemia/reperfusion.

Connell BJ, Saleh MC, Khan BV, Rajagopal D, Saleh TM.

Am J Physiol Regul Integr Comp Physiol. 2012 Apr;302(7):R886-95. doi: 10.1152/ajpregu.00644.2011. Epub 2012 Jan 25.

8.

Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model.

Connell BJ, Khan BV, Rajagopal D, Saleh TM.

Cardiol Res Pract. 2012;2012:319230. doi: 10.1155/2012/319230. Epub 2012 Jan 4.

9.

Lifestyle risk factors and cardiovascular disease in cubans and cuban americans.

Burroughs Peña MS, Patel D, Rodríguez Leyva D, Khan BV, Sperling L.

Cardiol Res Pract. 2012;2012:470705. doi: 10.1155/2012/470705. Epub 2011 Nov 23.

10.

Apocynin may limit total cell death following cerebral ischemia and reperfusion by enhancing apoptosis.

Connell BJ, Saleh MC, Khan BV, Saleh TM.

Food Chem Toxicol. 2011 Dec;49(12):3063-9. doi: 10.1016/j.fct.2011.09.010. Epub 2011 Sep 16.

PMID:
21946070
11.
12.

The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study.

Rahman ST, Merchant N, Haque T, Wahi J, Bhaheetharan S, Ferdinand KC, Khan BV.

J Cardiovasc Pharmacol Ther. 2012 Jun;17(2):139-45. doi: 10.1177/1074248411413282. Epub 2011 Jul 12.

PMID:
21750253
13.

Protected carotid artery stenting in patients at high risk for carotid endarterectomy.

Kumar PV, Lakshmi A, Shrivastava R, Mundi A, Tandon A, Desouza KA, Caldito G, Jimenez E, Khan BV, Tandon N.

South Med J. 2011 Apr;104(4):257-63. doi: 10.1097/SMJ.0b013e31820d8e39.

PMID:
21606693
14.

Cellular mechanisms by which lipoic acid confers protection during the early stages of cerebral ischemia: a possible role for calcium.

Richard MJ, Connell BJ, Khan BV, Saleh TM.

Neurosci Res. 2011 Apr;69(4):299-307. doi: 10.1016/j.neures.2010.12.011. Epub 2010 Dec 24.

PMID:
21185885
15.

Lipoic acid protects against reperfusion injury in the early stages of cerebral ischemia.

Connell BJ, Saleh M, Khan BV, Saleh TM.

Brain Res. 2011 Feb 23;1375:128-36. doi: 10.1016/j.brainres.2010.12.045. Epub 2010 Dec 21.

PMID:
21172313
16.

Raising HDL cholesterol in women.

Eapen DJ, Kalra GL, Rifai L, Eapen CA, Merchant N, Khan BV.

Int J Womens Health. 2010 Aug 9;1:181-91.

17.

A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients.

Bramlage P, Böhm M, Volpe M, Khan BV, Paar WD, Tebbe U, Thoenes M.

J Clin Hypertens (Greenwich). 2010 Sep;12(9):666-77. doi: 10.1111/j.1751-7176.2010.00322.x.

18.

Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress.

Merchant N, Rahman ST, Ferdinand KC, Haque T, Umpierrez GE, Khan BV.

J Hum Hypertens. 2011 Mar;25(3):196-202. doi: 10.1038/jhh.2010.39. Epub 2010 Apr 8.

PMID:
20376076
19.

Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use.

Hoskins MH, Leleiko RM, Ramos JJ, Sola S, Caneer PM, Khan BV.

J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):47-52. doi: 10.1177/1074248409358409.

PMID:
20133495
20.

Do the current medical and economic times dictate the need for the "polypill"?

Rifai L, Khan BV.

J Clin Hypertens (Greenwich). 2009 Dec;11(12):775-6. doi: 10.1111/j.1751-7176.2009.00188.x. No abstract available.

Supplemental Content

Loading ...
Support Center